The Department of Biotechnology, Ministry of Science and Technology, Government of India is supporting the implementation of the Ind-CEPI Mission,“Epidemic preparedness through rapid vaccine development: Support of Indian vaccine development aligned with the global initiative of the Coalition for Epidemic Preparedness Innovations (CEPI), through a dedicated Program Management Unit (PMU) at Biotechnology Industry Research Assistance Council (BIRAC).

The Ind-CEPI Mission was approved on 27th March 2019 with a total cost INR312.92 crore.

Ind-CEPI Mission aims to strengthen the development of vaccines for the diseases of epidemic potential in India as well as build coordinated preparedness in the Indian public health system and vaccine industry to address existing and emergent infectious threats in India.

The objectives of the mission include: 1. Supporting the development of at least 2-3 new vaccines for potential outbreak threats up to phase 2 testing in five years. 2. Strengthening of infrastructure to support the needs of the vaccine development through an academia-industry interface. 3. Supporting capacity building and skill development. 4. Strengthening internal inter-ministerial co-ordination for rapid vaccine development and testing to address known and unknown infectious disease threats. 5. Strengthening of development frameworks, surveillance and logistics for use of new vaccines, where appropriate.

For complete guidelines:

https://www.birac.nic.in/webcontent/1578542774_Guidelines_IndCEPI.pdf

Ind-CEPI Mission aims to strengthen the development of vaccines for the diseases of epidemic potential in India